INLD alleges medicine purchase “scam” in Haryana, demands CBI probe

Chandigarh: Haryana’s main opposition Indian National Lok Dal (INLD) today alleged there were irregularities to the tune of hundreds of crores in the purchase of medicines in state government hospitals and demanded a CBI probe in the matter.

Norms were violated in the purchases made at the district level by the concerned officials over the past three years, INLD’s Hisar MP Dushyant Chautala told a news conference here.

He claimed that over the past one year the INLD gathered information from the five districts of Rewari, Hisar, Faridabad, Rohtak and Jind through the RTI mode, and alleged the “scam” in these districts was pegged to be at Rs 125 crore.

“We have sought replies to our RTI queries from all the 22 districts, but today we are presenting before the media the information we have collated from the five districts. According to our estimates, the total scam woulf be well over Rs 300 crore and therefore, we are demanding a CBI inquiry into this,” Chautala said.

According to the Government of Haryana, anything that has to be bought has to be purchased from a centralised quotation, which is approved by the state government and forwarded to various districts, he said.

“There is a centralised purchase committee for buying of any kind of medicines or implements which are used in hospitals, for example cotton rolls, face masks, medicines and other equipment etc. Over the past three years, there has been a government centralised tender, but every district called for their own quotations too, violating norms. They have not purchased at tender mode. Some items were purchased at highly inflated rates. For example, a face mask is worth 95 paise, but in Fatehabad that mask was purchased for Rs 4.95,” alleged Chautala.

He claimed that in Rohtak, there was a purchase of Hepatitis B medicine worth Rs three crore in a period of three-and-a-half months, but that purchase was not approved by any committee. Purchases were made with average quotations being above Rs 19 lakh, he claimed.

“According to state government rules, all tenders above Rs 5 lakh should be put on an on-line portal, but nowhere the process has been followed. We have evidences to back this,” he said.

In Jind district, where pregnancy strip government tender rate is Rs 2.80, it was purchased at the rate of Rs 28, Chautala claimed.

He said the purchases were made under various schemes including the National Health Mission and “Mukhya Mantri Muft Ilaaj Yojana.

Chautala also said that in some cases fake addresses were given of the companies/stores from where the purchases were made.

“In one case, the address given turned out to be of a ‘Dhobi’ shop,” he claimed.

  • Related Posts

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi:  Patient safety in hospitals is a global concern, more so in India. It…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines